SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ICN Pharmaceuticals

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: IRWIN JAMES FRANKEL who wrote (800)9/28/1998 9:34:00 PM
From: Robohogs  Read Replies (1) of 1029
 
OT OT OT

IJ -

I am now beginning to give up hope for our favorite little friend. Yes, I believe earnings will be above $3 per share next year, but the market cannot be this dumb. I want to buy more shares in here (near my average cost after averaging up) but I just have too much in this one. Any other ideas you're looking at? I know you once owned ASND - have you looked at COMS in here? Looks cheap. Good luck. Let's hope our ICN plays out, but I'm now diversifying away from ICN - now only 15% of my porfolio down from 33%. ASND (takeout by LU looming at $65), CNTO (RA approval will yield $55 with a PE of 5x ICN's PE), ELN (PE moving ever higher) and APOS (a true future homerun) now dominate that portfolio with COMS growing.

Only time will tell.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext